Peter Vajkoczy

Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation

Ulrike Fiedler, Yvonne Reiss, Marion Scharpfenecker et al. · Nature Medicine · 2006 · 896 citations

Inflammation, Endothelial Cell Pathobiology, Cytokine +14

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

R. Loch Macdonald, Randall T. Higashida, E. Keller et al. · The Lancet Neurology · 2011 · 625 citations

Placebo-controlled Phase 3, Endovascular Technique, Vascular Surgery +5

Combined inhibition of VEGF‐ and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanisms

Ralf Erber, Andreas Thurnher, A. D. Katsen et al. · The FASEB Journal · 2003 · 600 citations

Biomedical Engineering, Tumor Biology, Angiogenesis +16

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack et al. · The Lancet · 2019 · 556 citations · Full text

Hematological Malignancy, Neuro-oncology, Treatment Strategies +13

Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage

Jens P. Dreier, Sebastian Major, Andrew Manning et al. · Brain · 2009 · 537 citations · Full text